This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety and tolerability
study in adult healthy participants, including Japanese cohort. This study is designed to
assess co-administration of probe substrates with gepotidacin in study cohorts 1 to 3 and
establishing PK and safety in Japanese participants in cohort 4. Food effect will also be
evaluated in cohort 4.